News

WuXi Biologics enables development of multiple neutralizing antibodies for Novel Coronavirus

WuXi Biologics says it has established a 100+ R&D team dedicated to the development and manufacturing of multiple neutralizing antibodies for 2019-nCoV.

Jan 30, 2020

By : Team ABLE

Merck invests in € 250 million in a new Switzerland-based biotech facility

Merck has invested upto€ 250 million in a new facility in Corsier-sur-Vevey, Switzerland – the Merck Biotech Development Center.

Jan 28, 2020

By : Team ABLE

Council for Healthcare and Pharma recommends increased budget allocations & de-bottlenecking in healthcare

The Council hopes that the coming budget will address deficiencies while providing a strong impetus and necessary monetary allocations to capacity building.

Jan 28, 2020

By : Team ABLE

BIRAC announces call for proposal for setting up of E-YUVA Centres

The scheme provides funding support (through fellowship and research grant), technical and business mentoring, exposure to bioincubation model.

Jan 28, 2020

By : Team ABLE

Life sciences fraternity mourns Dr MK Bhan’s demise

As Secretary, DBT, Dr M K Bhan established many new Institutes, clusters and innovation support agencies to attempt a transformation of the biotechnology sector in the country.

Jan 28, 2020

By : Team ABLE